Early Hepatic Dysfunction Is Associated with a Worse Outcome in Patients Presenting with Acute Respiratory Distress Syndrome: A Post-Hoc Analysis of the ACURASYS and PROSEVA Studies.

Early Hepatic Dysfunction Is Associated with a Worse Outcome in Patients Presenting with Acute Respiratory Distress Syndrome: A Post-Hoc Analysis of the ACURASYS and PROSEVA Studies.

Bilirubin is well-recognized marker of hepatic dysfunction in intensive care unit (ICU) patients. Multiple organ failure often complicates acute respiratory distress syndrome (ARDS) evolution and is associated with high mortality. The effect of early hepatic dysfunction on ARDS mortality has been po...

Full description

Bibliographic Details
Main Authors: Stéphanie Dizier, Jean-Marie Forel, Louis Ayzac, Jean-Christophe Richard, Sami Hraiech, Samuel Lehingue, Anderson Loundou, Antoine Roch, Claude Guerin, Laurent Papazian, ACURASYS study investigators, PROSEVA Study Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4670098?pdf=render

Internet

http://europepmc.org/articles/PMC4670098?pdf=render

Similar Items